NASDAQ
Actinium Pharmaceuticals, Inc. (ATNM) has a free cash flow growth of -8.88% as of Friday, May 29, 2026. This represents a 550.93% decrease compared to its 12-month average of -1.36%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.